T

Takeda Cell Therapy

Tokyo, Japan Founded 1781 NYSE: TAK
Drug Delivery Cell Therapy Nano Cancer Nanotherapy Nanomedicine Gene Therapy Delivery Nano-Bio

About

Global pharmaceutical company with advanced cell therapy programs

Company Details

Type
public
Employees
49000+
Funding
Public

Key Products

  • TAK-007
  • TAK-102
  • Allovir
Visit Website

Related Companies

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States

J

JEOL Ltd

Tokyo, Japan